Article
Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes.
Leukemia & lymphoma - 1 Jan 2018
Zhang Yang, Cheng Zhao, Yan Wen-Zhe, Liu Su-Fang, Hu Chun-Hong, Zhang Guang-Sen
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.